Oesophageal Carcinoma Active Not Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Carcinoma of Esophagus / Esophageal Carcinoma / Carcinoma, Esophageal / Esophagus Carcinoma / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Oesophageal carcinoma NOS / Esophageal carcinoma NOS

IndicationStatusPhase
DBCOND0032513 (Oesophageal Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02757391CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsTreatment